Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China — Shao-Hong Yan (2020) | RDL Network
Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China
Margaretha Prins, Geert V.T. Roozen, Cilia R. Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Olivia A. C. Lamers, Jan Pieter R. Koopman, Annelieke C. Kruithof, Ingrid M. C. Kamerling, Romy C. Dijkland, Alicia C. de Kroon, Shohreh Azimi, Mariet C.W. Feltkamp, Marjan Kuijer, Simon P. Jochems, Mirjam H.M. Heemskerk, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens
Nguyen Thi Thuy Ngan, Le Thanh Hoang Nhat, Nguyen Ngo Vi, Ninh Thi Thanh Van, Nguyen Thi Hoang, Duong Van Anh, Phan Trieu, Nguyen Phu Huong Lan, Nguyen Hoan Phu, Nguyễn Văn Vĩnh Châu, David G. Lalloo, William Hope, Justin Beardsley, Sir Nicholas White, Ronald B. Geskus, Guy Thwaites, Damian J. Krysan, Luong Thi Hue Tai, Evelyne Kestelyn, Trần Quang Bình, Le Quoc Hung, Nguyen Le Nhu Tung,
Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford, Mahdi Mahdi, Helen Jeffers, Christine Mwasuku, Karolina Krassowska, Robin Fox, Ian Binnian, Victoria Glover, Stephen Bright, Christopher Butler, Jennifer Cane, Andreas Halner, Philippa C. Matthews, Louise Donnelly, Jodie L. Simpson, Jonathan Baker, Nabil T. Fadai, Stefan Peterson, Thomas Bengtsson, Peter J Barnes, Richard Russell,
Discussion(0)
No comments yet. Be the first to comment.